big ideas for global investors Search
   Members       Sign-up       Newsfeeds        Companies        Stock Directories       Research       Video       Funding   

TSX Top Traders: (TOG), (BB), (NAU), (NPC)

Category: Investment

Visit: Torc Oil and Gas Ltd.

New York, New York - February 5, 2013 ( newswire) staff:, an investor research portal specializing in sector research for independent investors reports on the top traders on the TSX for February 5th, 2013.

Torc Oil and Gas Ltd., (TSX:TOG) trading at $2.070 moved up $0.010 or 0.49% on a volume of 14,242,356 shares. Newswire

Research In Motion Limited (TSX:BB) trading at $16.230 gained $1.240 or 8.27% on a volume of 12,607,317 shares.

Research in Motion Ltd.'s flagship new BlackBerrys went on sale in the U.K. last week and went on sale in Canada today.

The phones have been available for pre-orders from Canadian carriers for several weeks, and while the carriers haven't revealed numbers, RIM and carriers executives say they are encouraged by orders and interest thus far.

Based on U.K. sales, Research in Motion has been seeing many stores sold out, particularly with the white version. The UK is also a very competitive market, so having this kind of experience in the early days has been viewed positively for the Blackberry 10.

As for Canadian carriers, purchase orders have already exceeded expectations.

Northland Resources S.A. (TSX:NAU) trading at $0.130 dropped by $-0.040 or -23.53% on a volume of 8,546,673 shares.

Northland Resources S.A. announced (with reference made to the Company's press releases dated January 25 and 29, 2013) that the previously announced contemplated USD 250 million equity issue and USD 125 million tap issue have been cancelled. The Company continues to engage in constructive discussions with a number of investors, including bondholders, creditors and other stakeholders in order to present a sustainable long-term financial solution.

Allon Therapeutics Inc., (TSX:NPC) trading at $0.005 lowered by $-0.010 or -66.67% on a volume of 3,073,800 shares.

Allon Therapeutics Inc., is currently under de-listing review from TSX with respect to meeting the continued listing requirements. The Company has been granted 120 days in which to regain compliance with these requirements, pursuant to the Remedial Review Process.

About TSX

About is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including biotech, tech, mining, energy, water, renewable energy, beverage stocks and more .

Follow on Twitter!/Investorideas

Follow on Facebook

Follow News on at

Sign up for the free investor news and stock alerts at

Become an Member and access our 14 online stock directories 24/7 - water, renewable energy, mining stocks and more…

Disclaimer/ Disclosure : The is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.

BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info:

800-665-0411 - Source -

Join Investor Ideas Members to access the Renewable Energy stocks directory, water stocks, biotech stocks, defense stocks directories and the Insiders Corner


Investor Ideas © 2000 - 2015®, ECON


login | logout | about us | contact | disclaimer / disclosure |
partners / links | job search | privacy policy |
advertise | trade | sitemap |